Research and Markets: Necitumumab (Non-Small Cell Lung Cancer) - Forecast ... The Herald | HeraldOnline.com Research and Markets: Necitumumab (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022. Published: September ... Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, India and China. Key Topics Covered:. Research and Markets: LDK378 (Non-Small Cell Lung Cancer) - Forecast and ... Ganetespib (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022 |
